Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein

Abstract

Studies have revealed that human adenovirus-encoded E1A protein promotes cell proliferation through the targeted interaction with cellular proteins that act as key negative regulators of cell growth. The targets of E1A protein include the retinoblastoma tumor suppressor protein (pRb). Because p202, an interferon (IFN)-inducible murine protein (52-kDa), negatively regulates cell growth in part through the pRb/E2F pathway, we tested whether the p202 is a target of the adenovirus-encoded E1A protein for functional inactivation. Here we report that the expression of E1A protein overcame p202-mediated inhibition of cell growth and this correlated with an alleviation of p202-mediated inhibition of the transcriptional activity of E2F. Furthermore, E1A protein relieved p202-mediated inhibition of the specific DNA-binding activity of E2F complexes, including those containing the pocket proteins. Additionally, the E1A protein bound to p202 both in vitro and in vivo and a deletion of four amino acids in the conserved region 2 (CR2) of E1A protein significantly reduced the binding of E1A to p202. Interestingly, ectopic expression of p202 under reduced serum conditions significantly reduced E1A-mediated apoptosis. Taken together, our observations provide support to the idea that the p202 and adenovirus E1A protein functionally counteract each other and E1A protein targets p202 to promote cell proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Ackrill AM, Foster GR, Laxton CD, Flavell DM, Stark GR, Kerr IM . 1991 Nucl. Acids Res. 19: 4387–4393

  • Bagchi S, Raychaudhuri P, Nevins JR . 1990 Cell 62: 659–669

  • Brockmann D, Esche H . 1995 Curr. Top. Microbiol. Immunol. 199: 81–112

  • Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ . 1999 J. Biol. Chem. 274: 23358–23367

  • Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR . 1992 Proc. Natl. Acad. Sci. USA 89: 4549–4553

  • Choubey D . 2000 J. Biol. Regul. Homeost. Agents. 14: 187–192

  • Choubey D, Gutterman JU . 1997 Oncogene 15: 291–302

  • Choubey D, Lengyel P . 1992 J. Cell. Biol. 116: 1333–1341

  • Choubey D, Lengyel P . 1993 J. Interferon Res. 13: 43–52

  • Choubey D, Lengyel P . 1995 J. Biol. Chem. 270: 6134–6140

  • Choubey D, Li SJ, Datta B, Gutterman JU, Lengyel P . 1996 EMBO J. 15: 5668–5678

  • Choubey D, Snoddy J, Chaturvedi V, Toniato E, Opdenakker G, Thakur A, Samanta H, Engel D, Lengyel P . 1989 J. Biol. Chem. 264: 17182–17189

  • Condorelli G, Giordano A . 1997 J. Cell. Biochem. 67: 423–431

  • Cress WD, Nevins JR . 1996 Curr. Top. Microbiol. Immunol. 208: 63–78

  • Datta B, Li B, Choubey D, Nallur G, Lengyel P . 1996 J. Biol. Chem. 271: 27544–27557

  • Datta B, Min W, Burma S, Lengyel P . 1998 Mol. Cell. Biol. 18: 1074–1083

  • De Stancina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW . 1998 Genes Dev. 12: 2434–2442

  • D'Souza S, Xin H, Walter S, Choubey D . 2001 J. Biol. Chem. 276: 298–305

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Fattaey AR, Harlow Ed, Helin K . 1993 Mol. Cell. Biol. 13: 7267–7277

  • Flint J, Shenk T . 1997 Annu. Rev. Genet. 31: 177–212

  • Geng Y, Choubey D . 2000 J. Biol. Regul. Homeost. Agents 8: 263–268

  • Geng Y, D'Souza S, Xin X, Walter S, Choubey D . 2000 Cell Growth Diff. 11: 475–483

  • Gutterman JU, Choubey D . 1999 Cell Growth Diff. 10: 93–100

  • Harlow E, Whyte P, Franza BR, Schley C . 1986 Mol. Cell. Biol. 6: 1579–1589

  • Hertel L, Rolle S, De Andrea M, Azzimonti B, Osello R, Gribaudo G, Gariglio M, Landolfo S . 2000 Oncogene 19: 3598–3608

  • Jansen-Durr P . 1996 Trend Genet. 12: 270–275

  • Jones N . 1995 Curr. Top. Microbiol. Immunol. 199: 59–80

  • Kaelin Jr WG, Ewen M, Livingston DM . 1990 Mol. Cell. Biol. 10: 3761–3769

  • Kalvakolanu DVR, Bandyopadhyay SK, Harter ML, Sen GC . 1991 Proc. Natl. Acad. Sci. USA 88: 7459–7463

  • Koul D, Lapushin R, Xu HJ, Mills GB, Gutterman GU, Choubey D . 1998 Biochem. Biophys. Res. Commun. 247: 379–382

  • Lengyel P, Choubey D, Li S-J, Datta B . 1995 Semin. Virol. 6: 203–213

  • Lillie JW, Green M, Green MR . 1986 Cell 46: 1043–1051

  • Ludlow JW, Skuse GR . 1995 Virus Res. 35: 113–121

  • Melamed D, Tiegenbrun N, Yardin A, Kimchi A . 1993 Mol. Cell. Biol. 13: 5255–5265

  • Min W, Ghosh S, Lengyel P . 1996 Mol. Cell. Biol. 16: 359–368

  • Missero C, Filvaroff E, Dotto GP . 1991 Proc. Natl. Acad. Sci. USA 88: 3489–3493

  • Nevins JR . 1992 Science 258: 424–429

  • Nevins JR . 1995 Curr. Top. Microbiol. Immunol. 199: 25–32

  • Nevins JR, Leone G, DeGregori J, Jakoi L . 1997 J. Cell. Physiol. 173: 233–236

  • Peeper DS, Zantema A . 1993 Mol. Biol. Rep. 17: 197–207

  • Raychaudhuri P, Bagchi S, Devoto SH, Kraus VB, Moran E, Nevins JR . 1991 Genes Dev. 5: 1200–1211

  • Sang N, Giordano A . 1997 J. Cell. Physiol. 170: 182–191

  • Schneider RJ, Shenk T . 1987 Annu. Rev. Biochem. 56: 317–332

  • Smith K, Ying B, Ball AO, Beard CW, Spindler KR . 1996 Virology 224: 184–197

  • Wang H, Liu CJ, Lu Y, Chatterjee G, Ma XY, Eisenman RN, Lengel P . 2000 J. Biol. Chem. 275: 27366–27376

  • Weintraub SJ, Prater CA, Dean DC . 1992 Nature 358: 259–261

  • Weinberg RA . 1995 Cell 81: 323–330

  • Weinberg RA . 1996 Cell 85: 457–459

  • White E . 1995 Curr. Top. Microbiol. Immunol. 199: 34–58

  • Whyte P, Ruley HE, Harlow Ed . 1988 J. Virol. 62: 257–265

  • Yan DH, Wen Y, Spohn B, Choubey D, Gutterman JU, Hung MC . 1999 Oncogene 18: 807–811

  • Zantema A, van der Eb AJ . 1995 Curr. Top. Microbiol. Immunol. 199: 1–32

  • Zhang HS, Postigo AA, Dean DC . 1999 Cell 97: 53–61

Download references

Acknowledgements

We thank Drs J Nevins, P Dotto, J Germino, PE Branton, and KR Spindler for generously providing reagents. We also thank Dr Qin, and Scott Walter for the technical help. This work was supported by a grant (CA69031) from the National Institutes of Health (to D Choubey).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Divaker Choubey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xin, H., D'Souza, S., Fang, L. et al. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein. Oncogene 20, 6828–6839 (2001). https://doi.org/10.1038/sj.onc.1204844

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204844

Keywords

This article is cited by

Search

Quick links